Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cancer Research

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2837324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective suppression of human papillomavirus transcription in non‐tumorigenic cells by 5‐azacytidine.

  1988cited by this paper
• Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies.

  1987cited by this paper
• Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines

  1987cited by this paper
• Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.

  1987cited by this paper
• Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas.

  1987cited by this paper
• Identification of the HPV‐16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

  1987cited by this paper
• Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.

  1987influential reference
• The upstream regulatory region of the human papilloma virus‐16 contains an E2 protein‐independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.

  1987cited by this paper
• Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

  1986cited by this paper
• Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

  1986cited by this paper
• Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells

  1986cited by this paper
• Inhibition of heat shock protein synthesis by heat-inducible antisense RNA.

  1986cited by this paper
• Growth requirements of murine bone marrow macrophages in serum-free cell culture.

  1986cited by this paper
• Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

  1986cited by this paper
• Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

  1985cited by this paper
• Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

  1985cited by this paper
• Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

  1985cited by this paper
• Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

  1985cited by this paper
• Injected anti-sense RNAs specifically block messenger RNA translation in vivo.

  1985cited by this paper
• Phenocopy of discoidin I-minus mutants by antisense transformation in Dictyostelium.

  1985cited by this paper
• A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

  1985influential reference
• Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

  1985cited by this paper
• A quantitative dot-immunobinding assay for proteins using nitrocellulose membrane filters.

  1984cited by this paper
• Hybridization of nucleic acids immobilized on solid supports.

  1984cited by this paper
• Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

  1984cited by this paper
• High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.

  1984cited by this paper
• The region of mouse mammary tumor virus DNA containing the long terminal repeat includes a long coding sequence and signals for hormonally regulated transcription.

  1982influential reference
• Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

  1982cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Obituary: Nobel Laureate Harald zur Hausen (1936 - 2023) -who dedicated his life to unraveling the role of infectious agents in the pathogenesis of human cancers

  2024cites this paper
• Human papillomavirus-associated head and neck squamous cell carcinoma cells rely on glycolysis and display reduced oxidative phosphorylation

  2024cites this paper
• Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk

  2023cites this paper
• Harald zur Hausen 1936-2023.

  2023cites this paper
• Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis.

  2023cites this paper
• Role of extracellular vesicle in human papillomavirus-associated cervical cancer

  2023cites this paper
• Prognostic value of high-risk HPV DNA and p16 INK4a immunohistochemistry in anal cancer patients: an individual patient data meta-analysis

  2021cites this paper
• Prognostic value of high-risk human papillomavirus DNA and p16INK4a immunohistochemistry in patients with anal cancer: An individual patient data meta-analysis.

  2021cites this paper
• OTT_A_239979 4145..4155

  2020influential citation
• Linking Human Papillomavirus to Human Cancer and Understanding Its Carcinogenic Mechanisms

  2020cites this paper
• Interfering Human Papillomavirus E6/E7 Oncogenes in Cervical Cancer Cells Inhibits the Angiogenesis of Vascular Endothelial Cells via Increasing miR-377 in Cervical Cancer Cell-Derived Microvesicles

  2020influential citation
• Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.

  2019cites this paper
• Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins.

  2019cites this paper
• Small size, big impact: how studies of small DNA tumour viruses revolutionized biology

  2019cites this paper
• Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches

  2018cites this paper
• Secondary Prevention of Uterine Cervical Cancer Secondary Prevention of Uterine Cervical Cancer

  2018cites this paper
• Human papillomavirus genome variants and head and neck cancers: a perspective

  2018cites this paper
• Secondary Prevention of Uterine Cervical Cancer

  2017cites this paper
• Caractérisation topologique d'interactions non-covalentes inter- et intramoléculaires

  2017cites this paper
• 2 History of Papillomavirus Research

  2017cites this paper
• Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations.

  2017cites this paper
• 5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells

  2016cites this paper
• Immunotherapy against cancer-related viruses

  2016cites this paper
• In vitro expression of HPV16 E7 linked to HMGB1 immunoadjuvant in mammalian cells.

  2016cites this paper
• Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea

  2016cites this paper
• Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells

  2015cites this paper
• Human Papillomaviruses: Cervical Cancer and Warts

  2014cites this paper
• Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients

  2014cites this paper
• Human Papillomavirus: Pathogenesis and Host Immune Response

  2014cites this paper
• Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian

  2014cites this paper
• Tumors of the breast and female genital organs

  2014cites this paper
• 12 Evaluation of p 53 , p 16 INK 4 a and E-Cadherin Status as Biomarkers for Cervical Cancer Diagnosis

  2014cites this paper
• Identification of the deleted in split hand/split foot 1 protein as a novel biomarker for human cervical cancer.

  2013cites this paper
• Human papillomavirus genotyping and integration in ovarian cancer Saudi patients

  2013cites this paper
• Analysis of Pathways Affected by the Viral Oncogenes in Human Papillomavirus 16-Induced Neoplastic Progression

  2013cites this paper
• Cervical Carcinoma Cells by Repression of the Human Papillomavirus E7 Protein in Role of the Retinoblastoma Pathway in Senescence Triggered

  2013cites this paper
• Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany.

  2013cites this paper
• Human papillomavirus integration : the mechanism(s) behind the high-risk associated with this event and cervical disease progression

  2013cites this paper
• Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13.

  2013cites this paper
• Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV‐positive cancer cells

  2013cites this paper
• HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach.

  2013cites this paper
• Rekombinantní vakcíny proti solidním a hematologickým nádorům: vývoj a stanovení jejich účinnosti

  2013cites this paper
• 5 Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• Evaluation of p53, p16INK4a and E-Cadherin Status as Biomarkers for Cervical Cancer Diagnosis

  2012cites this paper
• Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction.

  2012cites this paper
• Physical Labeling of Papillomavirus-Infected, Immortal, and Cancerous Cervical Epithelial Cells Reveal Surface Changes at Immortal Stage

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• 1. The human papillomavirus

  2012cites this paper
• Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer

  2012cites this paper
• Effective gene silencing and inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs

  2012cites this paper
• Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

  2012cites this paper
• Causality in medicine with particular reference to the viral causation of cancers

  2011cites this paper
• Emerging topics in human tumor virology

  2011cites this paper
• Cell‐mediated immune response to human papillomavirus 16 E7 peptide pools in patients with cervical neoplasia

  2011cites this paper
• Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs

  2011cites this paper
• Aus der Klinik für Gynäkologie und Geburtshilfe - Direktor: Prof. Dr. med. W. Jonat - im Universitätsklinikum Schleswig-Holstein, Campus Kiel an der Christian-Albrechts-Universität zu Kiel "DIE ROLLE ANTIMIKROBIELLER PEPTIDE IM WEIBLICHEN GENITALTRAKT UNTER BESONDERER BERÜCKSICHTIGUNG HPV-ASSOZIIERT

  2011cites this paper
• PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro

  2011cites this paper
• Human Papillomavirus Integration and its Role in Cervical Malignant Progression

  2011cites this paper
• Evidence for a causal association for HPV in head and neck cancers

  2011cites this paper
• Expression of soluble TGF-β receptor II by recombinant Vaccinia virus enhances E7 specific immunotherapy of HPV16 tumors.

  2011cites this paper
• TA-CIN, a vaccine incorporating a recombinant HPV fusion protein (HPV16 L2E6E7) for the potential treatment of HPV16-associated genital diseases.

  2010cites this paper
• Modulation of apoptosis by early human papillomavirus proteins in cervical cancer.

  2010cites this paper
• In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

  2010cites this paper
• Comparison of cell growth suppression in SiHa cervical carcinoma cell line by human papillomavirus type 16 E6/E7 siRNAs

  2010cites this paper
• The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa.

  2009cites this paper
• E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.

  2009cites this paper
• Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma

  2009cites this paper
• Human papillomavirus infection, cancer & therapy.

  2009cites this paper
• Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells

  2009cites this paper
• siRNA and shRNA as anticancer agents in a cervical cancer model.

  2008cites this paper
• Human papillomavirus in cervical and head-and-neck cancer

  2008cites this paper
• Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.

  2007cites this paper
• The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.

  2007cites this paper
• Principles of Human Tumor Virology

  2007cites this paper
• Human papillomavirus and vaccination in cervical cancer.

  2007cites this paper
• The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus

  2007cites this paper
• Future of RNAi-based therapies for human papillomavirus-associated cervical cancer

  2007cites this paper
• Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA

  2007cites this paper
• Specific Apoptosis Induction in Human Papillomavirus-Positive Cervical Carcinoma Cells by Photodynamic Antisense Regulation

  2007cites this paper
• History of Papillomavirus Research

  2007cites this paper
• Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.

  2007cites this paper
• Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing.

  2007cites this paper
• The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors

  2007cites this paper
• Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region*

  2007cites this paper
• Human Papilloma Viruses: Realities and Perspectives

  2007cites this paper
• Human Papillomavirus E6 and E7 Oncogenes

  2007cites this paper
• Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.

  2007cites this paper
• Immune therapy against papillomavirus-related tumors in humans

  2006cites this paper
• Papillomavirus genome structure, expression, and post-transcriptional regulation.

  2006cites this paper
• Human papillomaviruses and cervical cancer.

  2006cites this paper
• E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients

  2006cites this paper
• SVEUILIŠTE U ZAGREBU

  2006cites this paper
• Human Papillomavirus 16 E6 Variants Are More Prevalent in Invasive Cervical Carcinoma than the Prototype1

  2006cites this paper
• Papillomaviruses as targets for cancer gene therapy.

  2006cites this paper
• Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosis

  2006cites this paper
• Papillomaviruses as targets for cancer gene therapy

  2006cites this paper
• Carcinoma Cell Lines Oligonucleotides on the Transformed Phenotype of Human Effects of Human Papillomavirus Type 18-specific Antisense

  2006influential citation
• Human Papillomavirus 16 E 6 Variants Are More Prevalent in Invasive Cervical Carcinoma than the Prototype 1

  2006cites this paper
• Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions

  2006cites this paper
• Viruses and Human Cancer

  2006cites this paper